Experience with CAPD in 14 patients, treated for periods of 2–10 months, is presented. Clinical and biochemical control of uremia appeared adequate in all patients except one. Control of extracellular volume and hypertension was easier with CAPD than with intermittent peritoneal dialysis (IPD). Nine episodes of peritonitis occurred in 5 patients (one peritonitis/8 patients months). Mean protein loss was 9.7 ± 2.7 g per day. In 6 patients on IPD oral glucose tolerance test resulted in a paradoxical rise of HGH, whereas this was not observed after 4 months of CAPD.
EbertR., FuchsC., GrentzfeldtW.: Sekretionsverhalten des Inulins und «gastric inhibitory polypeptide» bei niereninsuffizienten Patienten unter Dauer-Peritonealdialyse (CAPD),Nieren- und Hochdruckkrankheiten5, 208, 1979.
NolphK., HopkinsC., RubinJ., TwardowskiZ., PopovichR., van StoneJ.: Polymer induced ultrafiltration in dialysis: high osmotic pressure due to impermeant polymer sodium.Trans. Am. Soc. Artif. Intern. Organs24, 162, 1978.
5.
NolphK. D.: Peritoneal dialysis: physiology, current applications and future directions.Proc. Europ. Dial. Transpl. Assoc.16 (in press).
6.
OreopoulosD.G., RobsonM., IzattS., ClaytonS., de VeberG.A.: A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD).Trans. Amer. Soc. Artif. Intern. Organs24, 484, 1978.
7.
OreopoulosD. G.: The coming of age of continuous ambulatory peritoneal dialysis (CAPD).Dial. Transpl.8. 460, 1979.
8.
OreopoulosD.G., ClaytonS., DombrosN., ZellermanG., Katirtzoglou,: Nineteen months experience with continuous ambulatory peritoneal dialysis (CAPD).Proc. Europ. Dial. Transpl. Assoc.16 (in press).
9.
ØrskovH., ChristensenN.J.: Growth hormone in uremia. I. Plasma growth hormone, inulin and glucagon after oral and intravenous glucose in uremic subjects.Scand. J. Clin. Lab. Invest.27, 51, 1971.
10.
PopovichR.P., MoncriefJ.W., DecherdJ.B., BomarJ.B., PyleW.K.: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. (Abstr.) Trans.Amer. Soc. Artif. Intern. Organs, 5, 64, 1976.
RobsonM.D., OreopoulosD.G., ClaytonS., IzattS., RapoportA., de VeberG.A.: Comparison of intermittent with continuous peritoneal dialysis.Proc. Europ. Dial. Transpl. Assoc.15, 197, 1978.
13.
SorgeF., CastroL.A., NagelA., KesselM.: Serum glucose, insulin, growth hormone, free fatty acids and lipids: responses to high carbohydrate and to high fat isocaloric diets in patients with chronic, non-nephrotic renal failure.Horm. Metab. Res.7, 228, 1975.
14.
SpitzJ., RubensteinA.H., BersohnI., LawrenceA.M., KirstensL: The effect of dialysis on the carbohydrate intolerance of chronic renal failure.Horm. Metab. Res.2, 86, 1970.
15.
ThomsonN.M., WalkerR.G., WhitesideG., ScottD.F., AtkinsC.R.: Continuous ambulatory peritoneal dialysis (CAPD) in the treatment of end-stage renal failure.Proc. Europ. Dial. Trans. Assoc.16 (in press).
16.
WeichselbaumT. E.: An accurate rapid method for the determination of protein in small amounts of blood and plasma.Amer. J. Clin. Path.10, 40, 1946.
